2002
DOI: 10.1073/pnas.142123199
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo

Abstract: Retroviral reverse transcriptases contain a DNA polymerase activity that can copy an RNA or DNA template and an RNase H activity that degrades the viral RNA genome during reverse transcription. RNase H makes both specific and nonspecific cleavages; specific cleavages are used to generate and remove the polypurine tract primer used for plus-strand DNA synthesis and to remove the tRNA primer used for minus-strand DNA synthesis. We generated mutations in an HIV-1-based vector to change amino acids in the RNase H … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
112
1

Year Published

2003
2003
2013
2013

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 99 publications
(119 citation statements)
references
References 24 publications
6
112
1
Order By: Relevance
“…From these experiments, we conclude that, in MLV replication: (i) Raltegravir inhibits the DNA strand transfer (27) but not the 3Ј processing; (ii) Because it increases rather than decreases 2-LTR circle concentration, reverse transcriptase activity and DNA repair are not inhibited either; (iii) Trex1 degrades the 3Ј ends of retroviral DNA and also is not inhibited by raltegravir; and (iv) Because insertions at the circle junctions are generated by defective RNase H activity (35), but raltegravir treatment does not seem to increase their number (see Fig. 1B), RNase H probably is also unaffected.…”
Section: Raltegravir Inhibits MLV Integration and Causes Accumulationmentioning
confidence: 83%
“…From these experiments, we conclude that, in MLV replication: (i) Raltegravir inhibits the DNA strand transfer (27) but not the 3Ј processing; (ii) Because it increases rather than decreases 2-LTR circle concentration, reverse transcriptase activity and DNA repair are not inhibited either; (iii) Trex1 degrades the 3Ј ends of retroviral DNA and also is not inhibited by raltegravir; and (iv) Because insertions at the circle junctions are generated by defective RNase H activity (35), but raltegravir treatment does not seem to increase their number (see Fig. 1B), RNase H probably is also unaffected.…”
Section: Raltegravir Inhibits MLV Integration and Causes Accumulationmentioning
confidence: 83%
“…After HIV-1 vectors were described, replication-defective systems were engineered from molecular clones of non-primate and other primate lentiviruses [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19]. In addition to their use in pre-clinical gene therapy research, lentiviral vectors have been important tools for basic science [20][21][22][23][24][25][26][27][28]. This review concentrates on virological fundamentals of FIV-based lentiviral vector development, and discusses some recent lentivirological controversies and vector applications.…”
Section: Introductionmentioning
confidence: 99%
“…These residues are conserved between RNases H found in viruses, bacteria and humans 22,31,32 . Replacement of these residues with alanine in HIV-1 RT decreases the DNA synthesis rate and inhibits virus infectivity 33 . Overall, the backbone composition of nucleotides near the 59 end of the primer had a greater influence on enzyme binding orientation than those near the 39 end (Fig.…”
mentioning
confidence: 99%